C4 Therapeutics CCCC Q1 2026 Earnings Narrowing Losses Drive Surprise Beat Despite Zero Revenue Immunocore IMCR Q1 2026 Earnings Stunning EPS Beat Masks Caution as Shares Slide 39 Canopy Growth CGC Q1 2026 Earnings Deep EPS Miss Casts Shadow Over Cannabis Sector PLX Q1 2026 Earnings Massive EPS Surprise as Protalix BioTherapeutics Reports Strong Profitability AESI Q1 2026 Earnings EPS Misses Estimates by Wide Margin FGBI Q1 2026 Earnings EPS Surges 96 Above Estimates Stock Gains 4